ATEC stock icon

Alphatec Holdings
ATEC

$6.03
2.9%

Market Cap: $847M

 

About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Employees: 839

0
Funds holding %
of 6,728 funds
0
Analysts bullish %
of 11 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

40% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 63

34% more call options, than puts

Call options by funds: $3.42M | Put options by funds: $2.55M

1.66% less ownership

Funds ownership: 68.44% [Q1] → 66.78% (-1.66%) [Q2]

3% less funds holding

Funds holding: 222 [Q1] → 216 (-6) [Q2]

15% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 40

25% less capital invested

Capital invested by funds: $1.3B [Q1] → $976M (-$326M) [Q2]

75% less funds holding in top 10

Funds holding in top 10: 4 [Q1] → 1 (-3) [Q2]

Research analyst outlook

11 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$12
99%
upside
Avg. target
$18.27
203%
upside
High target
$25
315%
upside

11 analyst ratings

11 positive
100%
neutral
0%
negative
0%
Lake Street
Brooks O'Neil
44% 1-year accuracy
4 / 9 met price target
199%upside
$18
Buy
Maintained
3 Sept 2024
Canaccord Genuity
Caitlin Cronin
36% 1-year accuracy
4 / 11 met price target
232%upside
$20
Buy
Maintained
30 Aug 2024
Needham
David Saxon
41% 1-year accuracy
26 / 64 met price target
116%upside
$13
Buy
Maintained
22 Aug 2024
Piper Sandler
Matt O'Brien
49% 1-year accuracy
22 / 45 met price target
99%upside
$12
Overweight
Maintained
1 Aug 2024
Stifel
Mathew Blackman
44% 1-year accuracy
7 / 16 met price target
165%upside
$16
Buy
Maintained
1 Aug 2024

Financial journalist opinion